These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32401123)

  • 1. Prostate volume and age are predictors of energy delivery using the CoreTherm Concept in patients with LUTS/BPO: a study on thermal dose.
    Stenmark F; Brudin L; Kjölhede H; Peeker R; Stranne J
    Scand J Urol; 2020 Jun; 54(3):248-252. PubMed ID: 32401123
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk.
    Stenmark F; Brudin L; Kjölhede H; Peeker R; Stranne J
    Scand J Urol; 2022 Aug; 56(4):336-341. PubMed ID: 35942595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sufficient Volume Ablation with Photoselective Vaporization of the Prostate Delivers 5-Year Durability and Improves Symptom Relief for Larger Prostates.
    Otsuki H; Kuwahara Y; Kosaka T; Nakamura K; Tsukamoto T
    J Endourol; 2016 Jan; 30(1):102-8. PubMed ID: 25068651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-energy feedback microwave thermotherapy and intraprostatic injections of mepivacaine and adrenaline: an evaluation of calculated cell kill accuracy and responder rate.
    Stenmark F; Brudin L; Stranne J; Peeker R
    Scand J Urol; 2014 Aug; 48(4):374-8. PubMed ID: 24521182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical and interventional management of benign prostatic obstruction: Guidelines from the Committee for Male Voiding Disorders of the French Urology Association].
    Lebdai S; Chevrot A; Doizi S; Pradère B; Barry Delongchamps N; Baumert H; Benchikh A; Della Negra E; Fourmarier M; Gas J; Misraï V; Rouscoff Y; Theveniaud PE; Vincendeau S; Wilisch J; Descazeaud A; Robert G;
    Prog Urol; 2021 Apr; 31(5):249-265. PubMed ID: 33478868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent use of medical therapy after surgery for lower urinary tract symptoms: a retrospective database analysis.
    Ory J; Nackeeran S; Rainer Q; Smith N; Shah H; Ramasamy R
    World J Urol; 2022 Jan; 40(1):169-175. PubMed ID: 34435214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates.
    Nguyen DD; Barber N; Bidair M; Gilling P; Anderson P; Zorn KC; Badlani G; Humphreys M; Kaplan S; Kaufman R; So A; Paterson R; Goldenberg L; Elterman D; Desai M; Lingeman J; Roehrborn C; Bhojani N
    BJU Int; 2020 Jan; 125(1):112-122. PubMed ID: 31599044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of resistive index of the prostate and bladder sonomorphologic parameters as replacements for urodynamics to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Garg G; Sankhwar SN; Goel A; Pandey S; Sharma D; Parihar A
    Low Urin Tract Symptoms; 2019 May; 11(3):163-168. PubMed ID: 30793849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaporize, anatomically vaporize or enucleate the prostate? The flexible use of the GreenLight laser.
    Cindolo L; Ruggera L; Destefanis P; Dadone C; Ferrari G
    Int Urol Nephrol; 2017 Mar; 49(3):405-411. PubMed ID: 28044238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and Emerging Technologies in Treatment of Lower Urinary Tract Symptoms From Benign Prostatic Hyperplasia.
    Gupta NK; Gange SN; McVary KT
    Sex Med Rev; 2019 Jul; 7(3):491-498. PubMed ID: 29606553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapeutic targets to prevent benign prostatic enlargement and symptomatic progression to benign prostatic obstruction-ICI-RS 2023.
    Kanai A; Chakrabarty B; Winder M; Hashim H; Wein A; Abrams P; Fry C
    Neurourol Urodyn; 2024 Aug; 43(6):1363-1371. PubMed ID: 37916442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
    Jiang YH; Wang CC; Kuo HC
    PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses.
    Reale G; Marchioni M; Altieri V; Greco F; De Nunzio C; Destefanis P; Ricciardulli S; Bergamaschi F; Fasolis G; Varvello F; Voce S; Palmieri F; Divan C; Malossini G; Oriti R; Tuccio A; Ruggera L; Tubaro A; Delicato G; Laganà A; Dadone C; De Rienzo G; Ditonno A; Frattini A; Pucci L; Carrino M; Montefiore F; Germani S; Miano R; Schips L; Rabito S; Ferrari G; Cindolo L
    Minerva Urol Nefrol; 2020 Oct; 72(5):622-628. PubMed ID: 32284526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Three horse shoe-like incision" holmium laser enucleation of the prostate: first experience with a novel en bloc technique for anatomic transurethral prostatectomy.
    Miernik A; Schoeb DS
    World J Urol; 2019 Mar; 37(3):523-528. PubMed ID: 30039386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes.
    Al-Rawashdah SF; Pastore AL; Salhi YA; Fuschi A; Petrozza V; Maurizi A; Illiano E; Costantini E; Palleschi G; Carbone A
    World J Urol; 2017 Oct; 35(10):1595-1601. PubMed ID: 28243790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robot-assisted simple prostatectomy for treatment of lower urinary tract symptoms secondary to benign prostatic enlargement: surgical technique and outcomes in a high-volume robotic centre.
    Pokorny M; Novara G; Geurts N; Dovey Z; De Groote R; Ploumidis A; Schatteman P; de Naeyer G; Mottrie A
    Eur Urol; 2015 Sep; 68(3):451-7. PubMed ID: 25887786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
    Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
    J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.